Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2023

Jun 16, 2023

33298_dirs_2023-06-15_601005ee-57b4-4cfe-8645-a8700c773ce9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-13

Reporting Person: Roberts Brad Michael (COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-13 Common Stock A 150000 Acquired 247632 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-06-13 Employee Stock Option (Right to Buy) $7.5 D 200000 Disposed Common Stock (200000) Direct

Footnotes

F1: The options are being cancelled in exchange for 150,000 restricted shares vesting on January 1, 2024 and performance shares to be reported until settlement. 35,000 of the stock options vested on January 8, 2021, with the remaining stock options scheduled to vest in equal monthly tranches, based on the passage of time, over the following 30 months.